explore -WSS

explore

author：knowledge 2025-09-28 09:17:18 - browse：293

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

explore

WSS

Friends ask where James Watson's attitudes about race came from

App could help diagnose ear infections more accurately — and at home

South Korea throws huge K

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Emergent cuts jobs, executive role in business shake

Friends ask where James Watson's attitudes about race came from

leisure time

explore

leisure time

Medicare details structure of new drug price negotiation program

The best solution to the drug shortages problem

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Wegovy trial has doctors encouraged over new possibilities

Duchenne breakthrough therapy leaves behind pioneering families

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

5 to watch: Tech startups trying to solve health care's staffing crisis

Anesthesiologist group: stop taking Ozempic before surgery

South Korea throws huge K

hotspot

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Plastic surgeons increase patient psychiatric screenings

Drastic changes should bring profitability, startup health insurers say

Man killed during FBI raid in connection with threats against Biden, other officials

In same hospitals, Black patients receive fewer opioids than white patients

Emergent cuts jobs, executive role in business shake

hotspot

hotspot

explore

focus